A decline in AhR protein levels and an increase in cytochrome P450 1A1 (CYP1A1) expression in a dose- and time-dependent manner observed after treatment with DIM demonstrate the correlation between AhR and gastric cancer [29]. This evidence concerns the gene AHR and gastric cancer.